Skip to content

Mesenchymal stem cell in rotator cuff tear

The evaluation of effectiveness of mesenchymal stem cell derived from autologous adipose tissue compared to platelet rich plasma on pain and functionality of the patients with total tear of shoulder rotator cuff tendons (The second phase of a clinical trial)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100718004409N16
Enrollment
30
Registered
2025-02-04
Start date
2025-03-05
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Full tear of shoulder rotator cuff tendon. Rotator cuff tear or rupture, not specified as traumatic

Interventions

Intervention 1: Intervention group: First, 20 to 30 cc of fat is collected via liposuction in sterile conditions from the abdomen and flank areas of the patient and sent to the hospital's Motahari Cle

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: Chronic shoulder pain (lasting over three months) Confirmed complete tear of at least on tendon in shoulder MRI At least positive five clinical shoulder tests including Neer, Hawkins, Jobe, extension lag, drop arm, resisted external and internal rotation Age over 30 years

Exclusion criteria

Exclusion criteria: Active malignancy or history of malignancy in the last 5 years in any area of the body Calcific tendinitis Adhesive capsulitis History of receiving biological factor treatments in the past six months Partial tears of the rotator cuff tendons Emergency surgical indications

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before intervention and 1, 3, 6 months after injection. Method of measurement: Visual Analogue Scale Score.;Tendon tear repair. Timepoint: Before intervention, 6 months after injection. Method of measurement: Magnetic Resonance Imaging.

Secondary

MeasureTime frame
Joint range of motion. Timepoint: Before intervention and 1, 3, 6 months after injection. Method of measurement: Hand held goniometry.;Muscle strength. Timepoint: Before intervention and 1, 3, 6 months after injection. Method of measurement: Muscle strength testing scale on 1-5.;Functionality. Timepoint: Before intervention and 1, 3, 6 months after injection. Method of measurement: Western Ontario Rotator Cuff and Disabilities of the Arm, Shoulder and Hand.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Nejati

Iran University of Medical Sciences

Parisanejati@yahoo.com+98 21 6435 2446

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026